AI-generated summary
The authors randomly assigned 34 inpatients with recurrent non-seasonal major depression to bright light therapy, imipramine, a combination, or dim red light in a double-blind study. All three groups improved significantly, and the bright light plus placebo group improved more than the others, though not significantly. The authors conclude that bright light therapy can be effective, but the sample was small.
- Participants
- 34
- Who or what was studied
- Inpatients with DSM-III-R diagnosed recurrent non-seasonal major depressive disorder
- Limits stated in the abstract
- The between-group difference was not statistically significant and the sample size of 34 is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.